SCHEMBL8934548

SCHEMBL8934548

Cc1c(-c2ccccc2)oc2c(CN(C)C)c(O)ccc2c1=O

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.62
KDM4E B2RXH2 10/20 0.56
HPGD P15428 10/20 0.56
GAA P10253 6/20 0.56
HSD17B10 Q99714 6/20 0.56
GLA P06280 5/20 0.56
CASP1 P29466 5/20 0.56
CASP7 P55210 5/20 0.56
L3MBTL1 Q9Y468 1/20 0.54
TSHR P16473 2/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
POLB P06746 1/20 0.49
LMNA P02545 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13453098 0.86 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDGAAHSD17B10
Dimefline SCHEMBL30539856 0.83 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDGAAHSD17B10
Dimefline SCHEMBL668130 0.83 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL18222875 0.83 KDM4E (0.67) ALDH1A1KDM4EHPGDGAAHSD17B10
Dimefline SCHEMBL121889 0.82 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL12325677 0.77 ALOX15 (0.64) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL8877681 0.76 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL14317878 0.75 SHBG (0.73) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL14266215 0.73 CYP1A2 (0.45) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL22266149 0.72 GAA (0.58) ALDH1A1KDM4EHPGDGAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO claimed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed